Associating IDH and TERT Mutations in Glioma with Diffusion Anisotropy in Normal-Appearing White Matter

References

1. 1.↵
   1. Ostrom QT,
   2. Patil N,
   3. Cioffi G, et al

   . CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 2020;22:iv1–96 doi:10.1093/neuonc/noaa200 pmid:33123732

   CrossRefPubMed
2. 2.↵
   1. Eckel-Passow JE,
   2. Lachance DH,
   3. Molinaro AM, et al

   . Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 2015;372:2499–508 doi:10.1056/NEJMoa1407279 pmid:26061753

   CrossRefPubMed
3. 3.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
4. 4.↵
   1. Parsons DW,
   2. Jones S,
   3. Zhang X, et al

   . An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807–12 doi:10.1126/science.1164382 pmid:18772396

   Abstract/FREE Full Text
5. 5.
   1. Brat DJ,
   2. Verhaak RG,
   3. Aldape KD, et al

   ; Cancer Genome Atlas Research Network. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 2015;372:2481–98 doi:10.1056/NEJMoa1402121 pmid:26061751

   CrossRefPubMed
6. 6.↵
   1. Killela PJ,
   2. Pirozzi CJ,
   3. Healy P, et al

   . Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget 2014;5:1515–25 doi:10.18632/oncotarget.1765 pmid:24722048

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Gao M,
   2. Lin Y,
   3. Liu X, et al

   . TERT mutation is accompanied by neutrophil infiltration and contributes to poor survival in isocitrate dehydrogenase wild-type glioma. Front Cell Dev Biol 2021;9:654407 doi:10.3389/fcell.2021.654407 pmid:33996815

   CrossRefPubMed
8. 8.↵
   1. Colebatch AJ,
   2. Dobrovic A,
   3. Cooper WA

   . TERT gene: its function and dysregulation in cancer. J Clin Pathol 2019;72:281–84 doi:10.1136/jclinpath-2018-205653 pmid:30696697

   Abstract/FREE Full Text
9. 9.↵
   1. Barbaro M,
   2. Fine HA,
   3. Magge RS

   . Scientific and clinical challenges within neuro-oncology. World Neurosurg 2021;151:402–10 doi:10.1016/j.wneu.2021.01.151 pmid:33610863

   CrossRefPubMed
10. 10.↵
    1. Sahm F,
    2. Capper D,
    3. Jeibmann A, et al

    . Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol 2012;69:523–26 doi:10.1001/archneurol.2011.2910 pmid:22158715

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Esmaeili M,
    2. Stensjøen AL,
    3. Berntsen EM, et al

    . The direction of tumour growth in glioblastoma patients. Sci Rep 2018;8:1199 doi:10.1038/s41598-018-19420-z pmid:29352231

    CrossRefPubMed
12. 12.↵
    1. Tysnes BB,
    2. Mahesparan R

    . Biological mechanisms of glioma invasion and potential therapeutic targets. J Neurooncol 2001;53:129–47 doi:10.1023/a:1012249216117 pmid:11716066

    CrossRefPubMed
13. 13.↵
    1. Zetterling M,
    2. Roodakker KR,
    3. Berntsson SG, et al

    . Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data. J Neurosurg 2016;125:1155–66 doi:10.3171/2015.10.JNS15583 pmid:26918468

    CrossRefPubMed
14. 14.↵
    1. Barajas RF Jr.,
    2. Hodgson JG,
    3. Chang JS, et al

    . Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology 2010;254:564–76 doi:10.1148/radiol.09090663 pmid:20093527

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Ellingson BM,
    2. Malkin MG,
    3. Rand SD, et al

    . Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 2010;31:538–48 doi:10.1002/jmri.22068 pmid:20187195

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Basser PJ,
    2. Pierpaoli C

    . Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209–19 doi:10.1006/jmrb.1996.0086 pmid:8661285

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Price SJ,
    2. Burnet NG,
    3. Donovan T, et al

    . Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion? Clin Radiol 2003;58:455–62 doi:10.1016/s0009-9260(03)00115-6 pmid:12788314

    CrossRefPubMed
18. 18.↵
    1. Inglese M,
    2. Brown S,
    3. Johnson G, et al

    . Whole-arain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study. AJNR Am J Neuroradiol 2006;27:2137–40 pmid:17110683

    PubMed
19. 19.↵
    1. Kleihues P,
    2. Soylemezoglu F,
    3. Schäuble B, et al

    . Histopathology, classification, and grading of gliomas. Glia 1995;15:211–21 doi:10.1002/glia.440150303 pmid:8586458

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Won YI,
    2. Chung CK,
    3. Kim CH, et al

    . White matter change revealed by diffusion tensor imaging in gliomas. Brain Tumor Res Treat 2016;4:100–06 doi:10.14791/btrt.2016.4.2.100 pmid:27867919

    CrossRefPubMed
21. 21.↵
    1. Jütten K,
    2. Mainz V,
    3. Gauggel S, et al

    . Diffusion tensor imaging reveals microstructural heterogeneity of normal-appearing white matter and related cognitive dysfunction in glioma patients. Front Oncol 2019;9:536 doi:10.3389/fonc.2019.00536 pmid:31293974

    CrossRefPubMed
22. 22.↵
    1. Maudsley AA,
    2. Roy B,
    3. Gupta RK, et al

    . Association of metabolite concentrations and water diffusivity in normal appearing brain tissue with glioma grade. J Neuroimaging 2014;24:585–89 doi:10.1111/jon.12063 pmid:24251857

    CrossRefPubMed
23. 23.↵
    1. Malaterre M

    . GDCM: Grassroots DICOM Library. https://gdcm.sourceforge.net/wiki/index.php/Main_Page. Accessed October 29, 2022
24. 24.↵
    1. Bazin PL,
    2. Cuzzocreo JL,
    3. Yassa MA, et al

    . Volumetric neuroimage analysis extensions for the MIPAV software package. J Neurosci Methods 2007;165:111–21 doi:10.1016/j.jneumeth.2007.05.024 pmid:17604116

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Jenkinson M,
    2. Bannister P,
    3. Brady M, et al

    . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–41 doi:10.1006/nimg.2002.1132 pmid:12377157

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Fawcett T

    . An introduction to ROC analysis. Pattern Recognition Letters 2006;27:861–74 doi:10.1016/j.patrec.2005.10.010

    CrossRefWeb of Science
27. 27.↵
    1. Goebell E,
    2. Fiehler J,
    3. Ding XQ, et al

    . Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients: a combined diffusion tensor imaging and ¹H-MR spectroscopy study. AJNR Am J Neuroradiol 2006;27:1426–31 pmid:16908551

    PubMed
28. 28.↵
    1. Kassubek R,
    2. Gorges M,
    3. Westhoff MA, et al

    . Cerebral microstructural alterations after radiation therapy in high-grade glioma: a diffusion tensor imaging-based study. Front Neurol 2017;8:286 doi:10.3389/fneur.2017.00286 pmid:28663738

    CrossRefPubMed
29. 29.↵
    1. Horváth A,
    2. Perlaki G,
    3. Tóth A, et al

    . Biexponential diffusion alterations in the normal-appearing white matter of glioma patients might indicate the presence of global vasogenic edema. J Magn Reson Imaging 2016;44:633–41 doi:10.1002/jmri.25202 pmid:26914855

    CrossRefPubMed
30. 30.↵
    1. Kallenberg K,
    2. Goldmann T,
    3. Menke J, et al

    . Abnormalities in the normal appearing white matter of the cerebral hemisphere contralateral to a malignant brain tumor detected by diffusion tensor imaging. Folia Neuropathol 2014;52:226–33 doi:10.5114/fn.2014.45563 pmid:25310733

    CrossRefPubMed
31. 31.↵
    1. Baykara E,
    2. Gesierich B,
    3. Adam R

    ; et al. Alzheimer’s Disease Neuroimaging Initiative. A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms. Ann Neurol 2016;80:581–92 doi:10.1002/ana.24758 pmid:27518166

    CrossRefPubMed
32. 32.↵
    1. Song SK,
    2. Sun SW,
    3. Ramsbottom MJ, et al

    . Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–36 doi:10.1006/nimg.2002.1267 pmid:12414282

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Uh J,
    2. Merchant TE,
    3. Li Y, et al

    . Differences in brainstem fiber tract response to radiation: a longitudinal diffusion tensor imaging study. Int J Radiat Oncol Biol Phys 2013;86:292–97 doi:10.1016/j.ijrobp.2013.01.028 pmid:23474114

    CrossRefPubMed
34. 34.↵
    1. Latini F,
    2. Fahlström M,
    3. Beháňová A, et al

    . The link between gliomas infiltration and white matter architecture investigated with electron microscopy and diffusion tensor imaging. Neuroimage Clin 2021;31:102735 doi:10.1016/j.nicl.2021.102735 pmid:34247117

    CrossRefPubMed
35. 35.↵
    1. Stadlbauer A,
    2. Ganslandt O,
    3. Buslei R, et al

    . Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 2006;240:803–10 doi:10.1148/radiol.2403050937 pmid:16926329

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Deng Z,
    2. Yan Y,
    3. Zhong D, et al

    . Quantitative analysis of glioma cell invasion by diffusion tensor imaging. J Clin Neurosci 2010;17:1530–36 doi:10.1016/j.jocn.2010.03.060 pmid:20869249

    CrossRefPubMed